arrow
E

Eyra Ortíz-Pérez

Instituto Politécnico Nacional
H指数:7
被引数:166

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biological Evaluation of Esters of 4-Carboxylate-1,2,3-triazine and Analogs as New Potential Anti-Mycobacterium tuberculosis Agents

4-羧酸酯-1,2,3-三嗪及其类似物的生物评价:作为新型潜在抗分枝杆菌结核病剂的潜力

2026-06-070
OA
Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti-Trypanosoma cruzi Agents: An In Silico and In Vitro Approach

利用具有抗锥虫活性的已获批药物的骨架来识别新型抗克氏锥虫剂:一种体外和体外方法

2026-04-180
OAAI
An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity

一种基于计算机模拟和体外实验的方法鉴定出具有抗锥虫活性的潜在锥虫硫素合成酶抑制剂

2026-04-030
OAAI
Identification of Novel Trypanosoma cruzi Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity

通过基于配体的虚拟筛选鉴定具有抗锥虫活性的FDA批准药物的新型克氏锥虫半胱氨酸蛋白酶抑制剂

2026-02-270
OAAI
Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents

设计、合成及体外和计算机生物学评价:源自天然产物的吡啶-2,5-二羧酸酯类衍生物作为抗锥虫病剂的研发

2025-09-280
OAAI
Antiparasitic Effect of Polyphenols and Terpenes from Natural Products Against Trypanosoma cruzi and Leishmania mexicana

天然产物中多酚和萜类化合物的抗寄生虫作用:针对克氏锥虫和利什曼原虫墨西哥亚种

2025-08-210
PRE
Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in Trypanosoma cruzi: Virtual Screening and In Vitro Studies

重新定位FDA批准的磺胺类药物作为克氏锥虫中潜在的碳酸酐酶抑制剂的虚拟筛选与体外研究

2025-05-010
OA
Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-N-oxide derivatives against Giardia lamblia, Trichomonas vaginalis, and Entamoeba histolytica. An in vitro and in silico approach
2024-10-290
OAAI
Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4-Oxadiazoles as Anti-Trypanosoma cruzi and Anti-Leishmania mexicana Agents

1,3,4-恶二唑作为抗克氏锥虫和抗墨西哥利什曼原虫药物的设计,合成以及体外和计算机评估

2024-10-230
PRE
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents

扩大quinoxaline-7-carboxylate 1,4-二-n-氧化物衍生物的酯作为潜在抗结核药的化学空间

2024-01-010
PRE